Charles M. Baum

2015

In 2015, Charles M. Baum earned a total compensation of $2.2M as President and Chief Executive Officer at Mirati Therapeutics, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$225,500
Option Awards$1,489,200
Salary$530,272
Other$2,814
Total$2,247,786

Baum received $1.5M in option awards, accounting for 66% of the total pay in 2015.

Baum also received $225.5K in non-equity incentive plan, $530.3K in salary and $2.8K in other compensation.

Rankings

In 2015, Charles M. Baum's compensation ranked 4,275th out of 13,638 executives tracked by ExecPay. In other words, Baum earned more than 68.7% of executives.

ClassificationRankingPercentile
All
4,275
out of 13,638
69th
Division
Manufacturing
1,565
out of 5,190
70th
Major group
Chemicals And Allied Products
568
out of 1,854
69th
Industry group
Drugs
450
out of 1,528
71st
Industry
Pharmaceutical Preparations
355
out of 1,182
70th
Source: SEC filing on April 20, 2017.

Baum's colleagues

We found three more compensation records of executives who worked with Charles M. Baum at Mirati Therapeutics in 2015.

2015

Mark Gergen

Mirati Therapeutics

Former Executive Vice President and Chief Operations Officer

2015

Isan Chen

Mirati Therapeutics

Executive Vice President and Chief Medical and Development Officer

2015

James Christensen

Mirati Therapeutics

Chief Scientific Officer

News

In-depth

You may also like